These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

155 related items for PubMed ID: 810634

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. [Parameters for the measurement of long-term effects of an orally administered drug in organic and functional circulatory disorders. Preliminary communication].
    Schuster CJ, von Ungern-Sternberg AF.
    ZFA (Stuttgart); 1976 Jan 20; 52(2):105-10. PubMed ID: 817527
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. [Clinical treatment of peripheral arterial occlusive diseases].
    Schulte B.
    Fortschr Med; 1976 Sep 23; 94(27):1500-4. PubMed ID: 823087
    [Abstract] [Full Text] [Related]

  • 5. [Vasoactive drugs in peripheral arterial perfusion disorders. Problems, principles and results of the determination of therapeutic efficacy].
    Heidrich H.
    Dtsch Med Wochenschr; 1985 Aug 02; 110(31-32):1219-24. PubMed ID: 3926447
    [No Abstract] [Full Text] [Related]

  • 6. [Plasma levels and biliary and urinary elimination of raubasine, dehydroergocristine and dihydroergotamine after venous administration in anesthetized dogs].
    Marzo A, Ghirardi P, Parenti MA, Merlo L, Marchetti G.
    Boll Soc Ital Biol Sper; 1975 Jun 15; 51(11):684-6. PubMed ID: 816365
    [No Abstract] [Full Text] [Related]

  • 7. [Therapy of organic psychosyndromes of cerebrovascular origin with a vasoactive drug combination].
    Lesch OM, Musalek M, Dietzel M, Grünberger J, Saletu B, Schjerve M, Walter H, Werner U, Zeiler K.
    Wien Med Wochenschr; 1985 Sep 30; 135(18):459-65. PubMed ID: 3933188
    [Abstract] [Full Text] [Related]

  • 8. [Quantitative rheographic study of the effects of a new drug combination: raubasine/dihydroergocristine].
    Henriet M, Jacquy J, Noel G.
    Brux Med; 1974 Dec 30; 54(12):743-5. PubMed ID: 4215548
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. [Conservative treatment of peripheral arterial occlusive diseases].
    Hoffmann J.
    Fortschr Med; 1978 Sep 14; 96(34):1735-8. PubMed ID: 101431
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. [Use of peripheral vasodilator drug in peripheral and cerebrovascular syndromes of old age].
    Andalò L, Missana M.
    Clin Ter; 1975 Sep 15; 74(5):471-84. PubMed ID: 819202
    [No Abstract] [Full Text] [Related]

  • 18. [Indications for and effects of vasodilating agents, especially in cerebral and peripheral vascular sclerosis].
    Offerhaus L.
    Ned Tijdschr Geneeskd; 1981 Feb 07; 125(6):228-34. PubMed ID: 7207673
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Hydergine-thioridazine combination in the treatment of psychopathological states in old age.
    Predescu V, Giurezu T, Tudorache D, Nica S, Ionescu R, Nicolschi L, Nitrurad A, Popvici E, Curelaru S.
    Act Nerv Super (Praha); 1974 Aug 07; 16(3):237-8. PubMed ID: 4214302
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.